These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 26223410)

  • 41. Strict versus liberal target range for perioperative glucose in patients undergoing coronary artery bypass grafting: a prospective randomized controlled trial.
    Desai SP; Henry LL; Holmes SD; Hunt SL; Martin CT; Hebsur S; Ad N
    J Thorac Cardiovasc Surg; 2012 Feb; 143(2):318-25. PubMed ID: 22137804
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Increased risk of cardiovascular mortality by strict glycemic control (pre-procedural HbA1c < 6.5%) in Japanese medically-treated diabetic patients following percutaneous coronary intervention: a 10-year follow-up study.
    Funamizu T; Iwata H; Nishida Y; Miyosawa K; Doi S; Chikata Y; Shitara J; Endo H; Wada H; Naito R; Ogita M; Dohi T; Kasai T; Okazaki S; Isoda K; Miyauchi K; Daida H
    Cardiovasc Diabetol; 2020 Feb; 19(1):21. PubMed ID: 32070335
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Home Alone.
    Tsai A
    Diabetes Forecast; 2015; 68(4):33-4, 36. PubMed ID: 26373218
    [No Abstract]   [Full Text] [Related]  

  • 44. Does pharmacologic treatment in patients with established coronary artery disease and diabetes fulfil guideline recommended targets? A report from the EUROASPIRE III cross-sectional study.
    Gyberg V; Kotseva K; Dallongeville J; Backer GD; Mellbin L; Rydén L; Wood D; Bacquer DD;
    Eur J Prev Cardiol; 2015 Jun; 22(6):753-61. PubMed ID: 24691153
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Decrease mortality in type II diabetes mellitus: glycemic and renal function control.
    Borghi C; Ventura F
    J Cardiovasc Med (Hagerstown); 2018 Feb; 19 Suppl 1():e13-e15. PubMed ID: 29538138
    [No Abstract]   [Full Text] [Related]  

  • 46. Monitoring blood glucose control: what does the future hold?
    Cameron B; Berard L
    Can J Diabetes; 2015 Jun; 39(3):190-1. PubMed ID: 25840944
    [No Abstract]   [Full Text] [Related]  

  • 47. All-cause mortality and pharmacological treatment intensity following a high risk screening program for diabetes. A 6.6 year follow-up of the ADDITION study, Denmark.
    Lauritzen T; Sandbaek A; Carlsen AH; Borch-Johnsen K
    Prim Care Diabetes; 2012 Oct; 6(3):193-200. PubMed ID: 22595031
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Facility-level variation in diabetes and blood pressure control in patients with diabetes: Findings from the Veterans Affairs national database.
    Rehman H; Akeroyd JM; Ramsey D; Ahmed ST; Merchant AT; Navaneethan SD; Petersen LA; Virani SS
    Clin Cardiol; 2017 Nov; 40(11):1055-1060. PubMed ID: 28841246
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Patient-important outcomes in diabetes--time for consensus.
    Montori VM; Gandhi GY; Guyatt GH
    Lancet; 2007 Sep; 370(9593):1104-6. PubMed ID: 17905147
    [No Abstract]   [Full Text] [Related]  

  • 50. Comment on "Perioperative blood glucose monitoring and control in major vascular surgery patients".
    Malmstedt J; Swedenborg J
    Eur J Vasc Endovasc Surg; 2010 Sep; 40(3):414-5; author reply 415. PubMed ID: 20624684
    [No Abstract]   [Full Text] [Related]  

  • 51. [Cardiovascular outcome trials in patients with diabetes].
    Mannucci E
    G Ital Cardiol (Rome); 2014 Dec; 15(12 Suppl 2):27S-31S. PubMed ID: 25623548
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The age of randomized clinical trials: three important aspects of randomized clinical trials in cardiovascular pharmacotherapy with examples from lipid and diabetes trials.
    Drexel H; Rosano GMC; Lewis BS; Huber K; Vonbank A; Dopheide JF; Mader A; Niessner A; Savarese G; Wassmann S; Agewall S
    Eur Heart J Cardiovasc Pharmacother; 2020 Apr; 6(2):97-103. PubMed ID: 31298686
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The use of real time continuous glucose monitoring or flash glucose monitoring in the management of diabetes: A consensus view of Italian diabetes experts using the Delphi method.
    Bruttomesso D; Laviola L; Avogaro A; Bonora E; Del Prato S; Frontoni S; Orsi E; Rabbone I; Sesti G; Purrello F;
    Nutr Metab Cardiovasc Dis; 2019 May; 29(5):421-431. PubMed ID: 30952574
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Mortality associated with less intense risk-factor control among adults with diabetes in the United States.
    Saydah SH; Gregg EW; Kahn HS; Ali MK
    Prim Care Diabetes; 2018 Feb; 12(1):3-12. PubMed ID: 28797537
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Impact of Blood Glucose Reporting on Glycemic Variability in Veterans With Diabetes.
    Mangrum C; Smith L; Shivaswamy V
    J Diabetes Sci Technol; 2015 Aug; 9(6):1348-9. PubMed ID: 26285952
    [No Abstract]   [Full Text] [Related]  

  • 56. Is glycemic control a quinidine-like intervention?
    Bloomgarden ZT
    J Diabetes; 2014 Sep; 6(5):387-8. PubMed ID: 24842383
    [No Abstract]   [Full Text] [Related]  

  • 57. Counterpoint: Intensive glucose control and mortality in ACCORD--still looking for clues.
    Riddle MC
    Diabetes Care; 2010 Dec; 33(12):2722-4. PubMed ID: 21115778
    [No Abstract]   [Full Text] [Related]  

  • 58. Impact of Diabetes Mellitus on Outcomes in Patients Supported With Left Ventricular Assist Devices: A Single Institutional 9-Year Experience.
    Asleh R; Briasoulis A; Schettle SD; Tchantchaleishvili V; Pereira NL; Edwards BS; Clavell AL; Maltais S; Joyce DL; Joyce LD; Daly RC; Kushwaha SS; Stulak JM
    Circ Heart Fail; 2017 Nov; 10(11):. PubMed ID: 29141856
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cardiovascular Risk in Diabetes Mellitus: Complication of the Disease or of Antihyperglycemic Medications.
    Alvarez CA; Lingvay I; Vuylsteke V; Koffarnus RL; McGuire DK
    Clin Pharmacol Ther; 2015 Aug; 98(2):145-61. PubMed ID: 25963811
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Mismatch between ADA and AGS recommendations for glycated hemoglobin targets for older adults.
    Tasci I; Safer U; Naharci I; Sonmez A
    Prim Care Diabetes; 2018 Apr; 12(2):192-194. PubMed ID: 29396204
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.